9 Meters Biopharma Total Revenue

As of the most recent data (March 2023), NMTR shows a total revenue of $0. In the prior-year period, the figure was $0. That is below the Technology sector average of $29T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NMTR's total revenue is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether 9 Meters Biopharma is outperforming or lagging.

The Technology sector average total revenue is about $29T. 9 Meters Biopharma is at $0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how NMTR stacks up against individual peers as well.

Tracking NMTR's total revenue over time shows whether 9 Meters Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has 9 Meters Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $0) with ownership activity and broader fundamentals.